The Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol and the Development of a Universal Influenza Vaccine

The Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol and the Development of a Universal Influenza Vaccine

Introduction:

New research has shed light on the interactions between Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) when consumed orally as part of cannabis edibles. Contradicting prior claims, the study found that CBD can actually enhance the effects of Δ9-THC when the two cannabinoids are consumed together. This discovery has important implications for individuals using cannabis products for therapeutic or nontherapeutic purposes.

The Effects of CBD on Δ9-THC Metabolism:

Previous research on the interactions between Δ9-THC and CBD focused primarily on inhalation or intravenous administration, resulting in conflicting findings. However, this new study specifically examined the effects of oral ingestion of both cannabinoids.

The researchers discovered that CBD inhibits the metabolism of Δ9-THC and its active metabolite, 11-OH-Δ9-THC. This inhibition reduces the clearance of these compounds from the body, prolonging exposure and resulting in stronger drug effects. Participants who ingested high doses of both Δ9-THC and CBD reported heightened anxiety, sedation, memory difficulties, and experienced worse cognitive and psychomotor function.

Understanding the Dosage and Dosing Adjustments:

The study used relatively high doses of Δ9-THC and CBD but within the range of FDA-approved therapeutic doses. These doses are similar to those found in products available for medicinal use in state-regulated dispensaries. The findings highlight the importance of considering possible dose adjustments for individuals using Δ9-THC-dominant or CBD-dominant products.

The Importance of a Universal Influenza Vaccine:

In other medical news, a clinical trial for a universal influenza vaccine developed by the National Institute of Allergy and Infectious Diseases' Vaccine Research Center has begun enrolling volunteers. The vaccine, known as H1ssF-3928 mRNA-LNP, aims to provide broad protection against multiple strains of the influenza virus.

Current seasonal flu vaccines require annual prediction of prevalent strains, leading to a potential decrease in efficacy if the dominant strains change unexpectedly. A universal flu vaccine would eliminate this issue by providing long-term immunity against a wide variety of strains, potentially reducing the need for yearly vaccinations.

The Potential of the mRNA Platform:

The H1ssF-3928 mRNA-LNP vaccine candidate is unique as it uses a messenger RNA (mRNA) platform. This mRNA platform, which has shown positive results in early clinical trials, allows for the development of different vaccines that provide strong and broad immunity against various strains.

By utilizing a specific portion of the flu protein called hemagglutinin (HA), researchers hope to induce long-term immunity against multiple flu viruses. The HA stem, which evolves slowly and remains consistent across different flu virus types, serves as the basis for the vaccine.

Conclusion:

The interactions between Δ9-THC and CBD highlight the need for dose adjustments in cannabis products. Additionally, the development of a universal influenza vaccine has the potential to revolutionize flu prevention by providing long-lasting immunity against a wide range of strains.

Actionable Advice:

1. Individuals using cannabis edibles or oral formulations should be aware of the potential for increased effects when Δ9-THC and CBD are consumed together. Consult with a healthcare professional for guidance on dosage adjustments.

2. Stay updated on the progress of the universal influenza vaccine and consider participating in clinical trials to contribute to the development of this groundbreaking medical advancement.

3. Maintain regular flu vaccinations until a universal vaccine is widely available. Seasonal flu vaccines remain important tools in controlling the spread and severity of influenza.

By understanding the interactions between cannabinoids and exploring innovative approaches to vaccine development, researchers are paving the way for improved healthcare outcomes and disease prevention.